| Patent | Date |
|---|
Compounds and Their Use for Reducing Uric Acid Levels
App 20220024900 - Piwinski; John J. ; et al. | 2022-01-27 |
Compounds and their use for reducing uric acid levels
Grant 11,168,075 - Piwinski , et al. November 9, 2 | 2021-11-09 |
Compounds and their use for reducing uric acid levels
Grant 11,161,835 - Piwinski , et al. November 2, 2 | 2021-11-02 |
Compounds and Their Use for Reducing Uric Acid Levels
App 20210236495 - Warrell, JR.; Raymond P. ; et al. | 2021-08-05 |
Compounds and their use for reducing uric acid levels
Grant 11,020,397 - Warrell, Jr. , et al. June 1, 2 | 2021-06-01 |
Compounds and Their Use for Reducing Uric Acid Levels
App 20200347034 - Piwinski; John J. ; et al. | 2020-11-05 |
Compounds And Their Use For Reducing Uric Acid Levels
App 20200339545 - Piwinski; John J. ; et al. | 2020-10-29 |
Compounds and their use for reducing uric acid levels
Grant 10,759,784 - Piwinski , et al. Sep | 2020-09-01 |
Compounds and Their Use for Reducing Uric Acid Levels
App 20200268757 - Warrell, JR.; Raymond P. ; et al. | 2020-08-27 |
Compounds and their use for reducing uric acid levels
Grant 10,752,613 - Piwinski , et al. A | 2020-08-25 |
Compounds and Their Use for Reducing Uric Acid Levels
App 20200197393 - Warrell, JR.; Raymond P. ; et al. | 2020-06-25 |
Compounds and their use for reducing uric acid levels
Grant 10,688,095 - Warrell, Jr. , et al. | 2020-06-23 |
Compounds And Their Use For Reducing Uric Acid Levels
App 20200017478 - Piwinski; John J. ; et al. | 2020-01-16 |
Compounds and Their Use for Reducing Uric Acid Levels
App 20200017477 - Piwinski; John J. ; et al. | 2020-01-16 |
Compounds and Their Use for Reducing Uric Acid Levels
App 20190117654 - Warrell, JR.; Raymond P. ; et al. | 2019-04-25 |
Bifunctional compounds and use for reducing uric acid levels
Grant 10,093,658 - Warrell, Jr. , et al. October 9, 2 | 2018-10-09 |
Bifunctional compounds and use for reducing uric acid levels
Grant 10,093,631 - Warrell, Jr. , et al. October 9, 2 | 2018-10-09 |
Bifunctional Compounds and Use for Reducing Uric Acid Levels
App 20180002315 - Warrell, JR.; Raymond P. ; et al. | 2018-01-04 |
Bifunctional Compounds and Use for Reducing Uric Acid Levels
App 20170197923 - Warrell, JR.; Raymond P. ; et al. | 2017-07-13 |
Methods for reducing uric acid levels using barbiturate derivatives
Grant 9,428,466 - Warrell, Jr. August 30, 2 | 2016-08-30 |
Methods for Reducing Uric Acid Levels Using Barbiturate Derivatives
App 20150133477 - Warrell, JR.; Raymond P. | 2015-05-14 |
Taxane compounds, compositions and methods
Grant 8,785,669 - Thottathil , et al. July 22, 2 | 2014-07-22 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 8,273,379 - Warrell, Jr. , et al. September 25, 2 | 2012-09-25 |
Taxane Compounds, Compositions And Methods
App 20120004429 - Thottathil; John K. ; et al. | 2012-01-05 |
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
App 20110091573 - Warrell, JR.; Raymond P. ; et al. | 2011-04-21 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 7,879,364 - Warrell, Jr. , et al. February 1, 2 | 2011-02-01 |
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
Grant 7,855,183 - Warrell, Jr. December 21, 2 | 2010-12-21 |
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
App 20100216867 - Warrell, JR.; Raymond P. ; et al. | 2010-08-26 |
Pharmaceutical Gallium Compositions and Methods
App 20090275655 - Warrell, JR.; Raymond P. ; et al. | 2009-11-05 |
Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them
Grant 7,119,217 - Jiang , et al. October 10, 2 | 2006-10-10 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 6,982,096 - Warrell, Jr. , et al. January 3, 2 | 2006-01-03 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 6,884,439 - Warrell, Jr. , et al. April 26, 2 | 2005-04-26 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 6,861,076 - Warrell, Jr. , et al. March 1, 2 | 2005-03-01 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 6,855,339 - Warrell, Jr. , et al. February 15, 2 | 2005-02-15 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 6,770,304 - Warrell, Jr. , et al. August 3, 2 | 2004-08-03 |
Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
Grant 6,723,351 - Warrell, Jr. , et al. April 20, 2 | 2004-04-20 |
Methods for detection of acute promyelocytic leukemia (APL)
Grant 5,843,642 - Dmitrovsky , et al. December 1, 1 | 1998-12-01 |
Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
Grant 4,880,811 - Warrell, Jr. November 14, 1 | 1989-11-14 |
Methods of treating bone disorders
Grant 4,704,277 - Bockman , et al. * November 3, 1 | 1987-11-03 |
Methods of treating bone disorders
Grant 4,686,104 - Bockman , et al. August 11, 1 | 1987-08-11 |
Use of gallium salts to treat disorders of calcium homeostasis
Grant 4,529,593 - Warrell, Jr. , et al. July 16, 1 | 1985-07-16 |
| 